Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic

BACKGROUND: Current guidelines recommend non-vitamin‑K oral anticoagulants (NOACs) as the first-choice therapy for stroke prevention in patients with atrial fibrillation (AF). The use of drugs in a clinical trial setting differs from that in real-world populations. Real-world data are important to a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Veer, A. J. W. M., Bennaghmouch, N., Wijffels, M. C. E. F., ten Berg, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890914/
https://www.ncbi.nlm.nih.gov/pubmed/31773474
http://dx.doi.org/10.1007/s12471-019-01330-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890914/
https://www.ncbi.nlm.nih.gov/pubmed/31773474
http://dx.doi.org/10.1007/s12471-019-01330-y

Ejemplares similares